Benign & Malignant Hematology Flashcards
t(15;17)
PML/RARA-alpha fusion protein
Diagnostic for APML
Passenger Lymphocyte Syndrome
B-lymphocytes from donor (often female) form antibodies that can attack the recipient’s RBCs
- can occur several days-weeks after allo-SCT
- Ex: Donor is blood group Group O Rh+ and Recipient is Group A Rh+; B-lymphocytes from donor make anti-A Abs against recipient’s RBCs resulting in hemolytic anemia
Hereditary Elliptocytosis
Hereditary defect in RBC membrane protein and RBC cytoskeleton (alpha-spectrin) that predisposes to hemolytic anemia
- Tx: Folic acid 1mg QD, transfusions PRN and splenectomy for select transfusion-dependent pta
Most likely mutation conferring resistance to Ibrutinib in patient with Stage IV CLL with +del 17p?
C481S mutation
- Ibrutinib is a BTK inhibitor that irreversibly covalently binds to C481 of the kinase; C481S mutation disrupts this binding and results in resistance to Ibrutinib
Large Granular Lymphocyte (LGL) Leukemia
- Clonal disorder of CD3+ cytotoxic T-cells or NK-cells (natural killer cells)
- Immunophenotype:
T-LGL: CD3+, CD8+, CD57+
NK-LGL: CD3(-), CD8+, CD57+ - Clinically p/w anemia, neutropenia and often asst’d with rheumatoid arthritis
- Dx: +TCR-gamma gene rearrangement detected on PCR
Felty’s Syndrome
Triad:
- Rheumatoid arthritis
- Splenomegaly
- Neutropenia
CP CML Risk Stratification
Sokal Risk: Age SM present Plts Blast %
Hasford Risk: Age SM present Plts Blast % Basophils Eosinophils
t(9;22)
BCR/ABL1 fusion gene = activated tyrosine kinase
- 5% of CML pts lack Philadelphia chromosome despite being positive for BCR/ABL rearrangement; most of these pts were found to have cryptic insertions between chrom 9 and 22 on FISH and were responsive to TKI therapy
Triad of IDA, esophageal webs and glossitis/angular cheilosis.
Plummer-Vinson Syndrome
Pts are at increased risk for SCC of esophagus and pharynx